IL15
Interleukin-15
Also known as: IL-15, IL15_HUMAN, MGC9721
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P40933
- Gene
- IL15
- Ensembl
- ENSG00000164136
- Chromosome
- 4
- Canonical length
- 162 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Nuclear speckles
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a cytokine that regulates T and natural killer cell activation and proliferation. This cytokine and interleukine 2 share many biological activities. They are found to bind common hematopoietin receptor subunits, and may compete for the same receptor, and thus negatively regulate each other's activity. The number of CD8+ memory cells is shown to be controlled by a balance between this cytokine and IL2. This cytokine induces the activation of JAK kinases, as well as the phosphorylation and activation of transcription activators STAT3, STAT5, and STAT6. Studies of the mouse counterpart suggested that this cytokine may increase the expression of apoptosis inhibitor BCL2L1/BCL-x(L), possibly through the transcription activation activity of STAT6, and thus prevent apoptosis. Alternatively spliced transcript variants of this gene have been reported. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
162 residues, UniProt reviewed canonical sequence.
>P40933|IL15
1 MRISKPHLRS ISIQCYLCLL LNSHFLTEAG IHVFILGCFS AGLPKTEANW VNVISDLKKI
61 EDLIQSMHID ATLYTESDVH PSCKVTAMKC FLLELQVISL ESGDASIHDT VENLIILANN
121 SLSSNGNVTE SGCKECEELE EKNIKEFLQS FVHIVQMFIN TSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 13 nTPM
- spleen: 13 nTPM
- lymph node: 9.1 nTPM
- small intestine: 8.4 nTPM
- skeletal muscle: 8.1 nTPM
- blood vessel: 7.7 nTPM
Single-cell type
- decidual stromal cells: 567 nCPM
- endometrial stromal cells: 381 nCPM
- cdc: 150 nCPM
- epicardial cells: 148 nCPM
- monocytes: 85 nCPM
- kupffer cells: 81 nCPM
Immune cell
- non-classical monocyte: 17 nTPM
- classical monocyte: 16 nTPM
- intermediate monocyte: 15 nTPM
- basophil: 10 nTPM
- total PBMC: 6.1 nTPM
- myeloid DC: 5.5 nTPM
Brain region
- medulla oblongata: 6.3 nTPM
- cerebellum: 5.8 nTPM
- cerebral cortex: 5.7 nTPM
- white matter: 5.5 nTPM
- pons: 5.3 nTPM
- thalamus: 5.1 nTPM
ReferencesPubMed · IEDB
Publications for IL15 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Combination of TACI-IgG and anti-IL-15 treats murine lupus by reducing mature and memory B cells.
2014 · Cell Immunol · RCR 0.4 · 14 citations - [Celiac disease: Novel pharmacological therapies].
2025 · Dtsch Med Wochenschr
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.71
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell maturation
- cell-cell signaling
- extrathymic T cell selection
- immune response
- interleukin-15-mediated signaling pathway
- lymph node development
- macrophage differentiation
- natural killer cell differentiation
- natural killer cell proliferation
- negative regulation of cold-induced thermogenesis
- neutrophil activation
- NK T cell proliferation
- positive regulation of cell population proliferation
- positive regulation of cytokine production
- positive regulation of immune response
- positive regulation of inflammatory response
- positive regulation of interleukin-17 production
- positive regulation of natural killer cell differentiation
- positive regulation of natural killer cell proliferation
- positive regulation of peptidyl-tyrosine phosphorylation
- positive regulation of phagocytosis
- positive regulation of T cell proliferation
- positive regulation of tissue remodeling
- regulation of defense response to virus by host
- regulation of T cell differentiation
- signal transduction
- tyrosine phosphorylation of STAT protein
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Interleukin-15/Interleukin-21 family
- Four-helical cytokine-like, core
- Interleukin 15
- Interleukin-15
- Interleukin-15, mammal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL15 as an antibody target. Whether an autoantibody or antibody against IL15 could matter depends on whether native IL15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL15 is annotated as secreted, so native IL15 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...